ARCHIVES

Abstracts of ‘Most Newsworthy’ Papers

This article is from The Cancer Letter archive.

Vol. 03 No. 22 | June 3, 1977

Download PDF Visit The Full Archive

Related Articles

Waksals Keep ImClone Jobs, BMS Pumps $200M Into C225

March 8, 2002

In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds

November 28, 1975

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

Cancer Letter Closes Out 1983, 10th Year

December 16, 1983

Phase II Study Tests Chemo Plus Mylotarg For AML

December 27, 2002

FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else”

September 5, 1980